共 93 条
[1]
Hamsten A(1987)Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 2: 3-9
[2]
de Faire U(1997)PAI-1, obesity, insulin resistance and risk of cardiovascular events Thromb Haemost 78: 656-660
[3]
Walldius G(1993)Impact of weight loss on plasminogen activator inhibitor-1 (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults Arterioscler Thromb Vasc Biol 13: 162-169
[4]
Dahlen G(1996)Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen. Effect of dieting with or without exercise in overweight postmenopausal women Arterioscler Thromb Vasc Biol 16: 381-385
[5]
Szamosi A(1996)Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction Am J Clin Nutr 64: 7-11
[6]
Landou C(1997)Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease Diabetes 46: 860-867
[7]
Blomback M(1996)Distribution and regulation of plasminogen activator inhibitor 1 in murine adipose tissue J Clin Invest 97: 37-46
[8]
Wiman B(1996)Elaboration of type 1 plasminogen activator inhibitor from adipocytes: A potential link between obesity and cardiovascular disease Circulation 93: 106-110
[9]
Juhan-Vague I(1998)Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals Diabetologia 41: 65-71
[10]
Alessi MC(1994)Percutaneous adipose tissue biopsy by mini-liposuction for metabolic studies JPEN Parenter Enter 18: 466-468